VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PRTCPureTech Health plc
$17.42$42M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPRTCEarnings History

PRTC logoPureTech Health plc (PRTC) Earnings History

Net Loss

14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$56M
● Net Loss
TTM EPS (Diluted)
$-23.20
Per share, diluted
YoY EPS Growth
-2400.0%
Declining
Net Margin
-2355.4%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-2114.7%
Gross Margin100.0%
Return on Equity-30.8%
Return on Assets-19.3%
Record Annual Net Income$421MFY2019
Record Quarterly EPS$5.80Q4 2019
Consecutive Profitable Years0years
Q4 2025
Net Income-$65M
EPS (Diluted)$-26.90
YoY Growth-2400.0%Declining
QoQ Growth-45.5%Declining

Loading earnings history...

PureTech Health plc (PRTC) Earnings Overview

As of June 23, 2026, PureTech Health plc (PRTC) reported trailing twelve-month net income of -$56M, reflecting -2400.0% year-over-year growth. The company earned $-23.20 per diluted share over the past four quarters, with a net profit margin of -2355.4%.

Looking at the long-term picture, PRTC's historical earnings data spans multiple years. The company achieved its highest annual net income of $421M in fiscal 2019.

PureTech Health plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including ROIV (-$300M net income, -3629.2% margin), ATAI (-$663M net income, -16142.0% margin), CMPS (-$179M net income), PRTC has outperformed on profitability metrics. Compare PRTC vs ROIV →

PRTC Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
PRTC logoPRTCCurrent
-$56M$-23.20-2355.4%-30.8%-2400.0%—
ROIV logoROIV
-$300M$-0.37-3629.2%-5.7%-79.2%
ATAI logoATAI
-$663M$-2.93-16142.0%-389.9%-212.9%
CMPS logoCMPS
-$179M$-1.91--565.3%-33.9%
RXRX logoRXRX
-$560M$-1.06-863.4%-59.5%+14.8%
ABSI logoABSI
-$118M$-0.77-4113.7%-62.5%+10.6%
Best in group
Lowest in group

PRTC Historical Earnings Data (2012–2025)

14 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$110M-305.1%-$99M$-46.00-2355.4%-2114.7%
2024$54M+181.4%-$136M$2.001108.3%-2818.9%
2023-$66M-30.5%-$146M$-2.40-1972.9%-4390.4%
2022-$50M+16.8%-$198M$-1.80-2409.3%-9464.4%
2021-$61M-1111.8%-$150M$-2.10-606.9%-1506.0%
2020$6M-98.6%-$120M$0.2071.8%-1433.1%
2019$421M+1064.7%-$135M$14.404847.4%-1558.5%
2018-$44M-241.4%-$104M$-1.60-266.7%-635.4%
2017$31M+163.3%-$115M$1.104749.1%-17756.9%
2016-$49M-23.9%-$74M$-2.10-1101.2%-1668.4%
2015-$39M+5.4%-$44M$-2.10-335.5%-371.7%
2014-$42M-867.8%-$17M$-5.10-2069.7%-867.0%
2013-$4M+61.1%-$4M$-0.80-61.3%-53.2%
2012-$11M--$9M$-1.60-139.4%-118.3%

Download Data

Export PRTC earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

14+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PRTC — Frequently Asked Questions

Quick answers to the most common questions about buying PRTC stock.

What is PRTC earnings per share (EPS)?

PRTC trailing twelve-month (TTM) diluted EPS is $-23.20, reflecting -2400.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.

What is PureTech Health plc's net income?

PureTech Health plc (PRTC) trailing twelve-month net income is $-56M as of 2025. Earnings declined -2400.0% year-over-year.

Is PRTC profitable?

PRTC is not currently profitable on a TTM basis, reporting a net loss of $-56M. Net margin is -2355.4%. Investors should monitor for a return to profitability.

What is PRTC's earnings growth rate?

PRTC compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.

What are PRTC's profit margins?

PureTech Health plc net profit margin is -2355.4%, operating margin is -2114.7%, and gross margin is +100.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -30.8%.

Is PRTC growing earnings?

PRTC earnings are declining — EPS fell -2400.0% year-over-year. TTM net income dropped to $-56M. This contrasts with the 5-year CAGR of N/A.

What was PRTC's best earnings year?

PureTech Health plc's highest annual net income on record is $421M, achieved in fiscal year 2019. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.

What were PRTC's earnings last quarter?

PRTC's most recent reported quarter was Q4 2025. Net income was $-65M with diluted EPS of $-26.90. For a full breakdown of all quarters, see the quarterly earnings table on this page.

PRTC Earnings Over Time (2012–2025)

Net income & EPS — annual and quarterly view